All the news

04 April 2024

By: Service de presse INRAE, Direction de la communication EnvA

COVID-19: A potential treatment for loss of smell

COMMUNIQUÉ DE PRESSE - L’un des symptômes persistants et invalidants de la Covid-19 est la perte de l'odorat (ou anosmie). Des scientifiques d’INRAE et de l’EnvA ont montré l'efficacité des corticoïdes dans la restauration des capacités olfactives impactées suite à l’infection virale. Ces résultats, parus le 27 février dans Brain, Behavior, and Immunity, marquent une avancée importante dans la compréhension et le traitement de ce symptôme.

04 April 2024

By: INRAE press office

Probing the protein used by SARS-CoV-2 to infect cells

PRESS RELEASE - To cause infection, viruses must enter the cells of their hosts. Viruses thus sport proteins on their membrane surfaces that allow their membranes to fuse with those of host cells. In collaboration with researchers at Cornell University in the US, INRAE researchers characterised a key surface protein found in SARS-CoV-2, the virus responsible for COVID-19. The group discovered that SARS-CoV-2 possesses a surface protein that is distinct from the surface proteins of other closely related coronaviruses. This difference in surface proteins might have played an important role in the evolution and emergence of SARS-CoV-2. These findings were recently published in the Journal of Molecular Biology.

31 October 2018

By: Christelle Langevin

Trout imaging using OPT microscopy

Our colleagues from zebrafish phenotyping platform recently attended MiFoBio microscopy meeting. Taking with them freshly clarified rainbow trout (4g) provided by IERP, they had the opportunity to image the whole specimen on an home made Optical Projection Tomography (OPT) microscope.
Marine Flavobacteria

03 June 2018

Cargèse (Corsica, France)

First International Conference on Marine Flavobacteria

It is with great pleasure that we announce that the First International Conference on Marine Flavobacteria will be held in Cargèse (Corsica, France), on June 4-8 2018.
© VIM, Inra Jouy-en-Josas, Jérôme Chapuis

14 September 2023

By: INRA service de presse

Prion diseases: toward further reduction of animal experimentation

Inra Scientists have developed an efficient method to amplify in vitro prion of different species. Beside its interest to rapidly address scientific questions, such as the study of the molecular mechanisms underlying prion propagation, this procedure represents a step forward to reduce the use of animal models in the prion field. This work is published in the 7th of July 2016 issue of the journal Scientific Reports.

16 March 2016


IAD 2016 - 10th French network for "Domestic Animal Immunology"

It is with great pleasure that we announce that the next IAD network symposium will be held in Ploufragan, France on March 17th-18th 2016.

24 November 2015

Paris (France)

ANIHWA Final Conference

The ANIHWA Consortium is pleased to invite you to the ANIHWA Final Conference, 25th- 26th November 2015, Paris, France.

14 September 2023

By: INRA News Office

SAPHIR: an international and multidisciplinary approach to developing new vaccines for livestock

SAPHIR is a project coordinated by INRA and selected by the European Commission for its Horizon 2020 programme. Participants launched the project with a seminar held on 11-13 May 2015 at INRA’s Jouy-en-Josas site. SAPHIR aims at developing innovative vaccination strategies against the pathogens responsible for major economic losses in cattle, pig and poultry farming. The project is the first of its kind to involve top-notch scientists from different disciplines (including pathologists, geneticists, microbiologists, sociologists, economists and mathematicians) in various public and private partnerships financed by Europe and China, using an integrated approach.
Flock of sheep marked after drafting at the Ruminants Experimental Unit in Theix

14 September 2023

By: INRA News Office

Scrapie could breach the species barrier

INRA scientists have shown for the first time that the pathogens responsible for scrapie in small ruminants (prions) have the potential to convert the human prion protein from a healthy state to a pathological state. In mice models reproducing the human species barrier, this prion induces a disease similar to Creutzfeldt-Jakob disease. These primary results published in Nature Communications on 16 December 2014, stress the necessity to reassess the transmission of this disease to humans.
Bioluminescence détectée chez une souris infectée par le virus respiratoire syncytial

14 September 2023

By: Service Presse

A new method for in vivo study of the virus that causes bronchiolitis

INRA research scientists, working in collaboration with Paris Public Hospitals (AP-HP) and the University of Versailles-Saint-Quentin-en-Yvelines, have developed a new method to study the virus that is mainly responsible for causing bronchiolitis in young children and calves. The in vivo and real-time visualisation of its replication in the mouse is now possible. At present, no treatment or vaccine enable the control of this infection in humans. This technological advance, published on 3 October 2014 in Nature Communications, will facilitate the tests used to determine vaccine efficacy and develop antiviral therapies.

14 September 2023

By: Jacques Le Rouzic

A new vaccine platform to protect against West Nile Virus

Research scientists in the Molecular Virology and Immunology Unit have developed a recombinant virus that procures partial protection against West Nile Virus in mice. This recombinant virus has proved to be a particularly interesting vector platform for the development of vaccines that can be used in animals and humans.
photo de microscopie du virus influenza

14 September 2023

By: Inra Transfert

New live attenuated influenza vaccines

In the frame of the Carnot Institute for Animal health “ICSA”, within the “Molecular Virology and Immunology” unit, INRA’s researchers steered by Dr Bernard Delmas have identified mutations within the Influenza A virus polymerase PA subunit that enable preparation of temperature-sensitive Influenza virus. They are now seeking industrial partners to transfer and develop this patented technology.
Service de néonatologie au CHU Hôtel-Dieu de Nantes, Hôpital Mère et Enfant. Les bébés prématurés y restent en couveuse jusqu'à la date théorique de leur naissance.

14 September 2023

By: INRA Press Service

Towards the First Pediatric Vaccine against Bronchiolitis

INRA and its partner DBV Technologies were just granted €600 000 by the French National Research Agency (ANR) to coordinate their know-how and develop an innovative and non-invasive vaccine against bronchiolitis. This subsidy launches a pre-clinical phase which will confirm the feasibility of a vaccine delivered via a skin patch for children under 2 years old.
“Tailor-made” antiviral compounds to fight influenza A

14 September 2023

By: INRA Press Service - Jacques Le Rouzic

“Tailor-made” antiviral compounds to fight influenza A

Scientists have identified on viral proteins the “nerve centres” which need to be targeted by therapeutic compounds in order to halt any proliferation that might cause influenza A. Using computer tools, it is possible to sketch the outlines of the antiviral compounds of tomorrow.

06 March 2013

Académie Vétérinaire de France

Nanotechnology in veterinary medicine

The French Veterinary Academy held the first conference on nanotechnology in veterinary medicine on 7 March 2013. The conference, organised by Bernard Charley at the INRA centre in Jouy-en-Josas, was an opportunity to present groundbreaking research on the subject, identify promising areas to pursue and discuss the foreseeable impact on veterinarian pharmacology and diagnostic capabilities.